The highest estimate is 46.00. From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
The current price of MPLT.BOATS is $7.98 USD — it has increased by +0% in the past 24 hours. Watch MapLight Therapeutics stock price performance more closely on the chart.
What is MapLight Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange MapLight Therapeutics stocks are traded under the ticker MPLT.BOATS.
What is MapLight Therapeutics market cap?▼
Today MapLight Therapeutics has the market capitalization of 443.49M
When is the next MapLight Therapeutics earnings date?▼
MapLight Therapeutics is going to release the next earnings report on December 3, 2026.
What were MapLight Therapeutics earnings last quarter?▼
MPLT.BOATS earnings for the last quarter are -1.32 USD per share, whereas the estimation was -1.35 USD resulting in a +2.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MapLight Therapeutics revenue for the last year?▼
MapLight Therapeutics revenue for the last year amounts to 0 USD.
What is MapLight Therapeutics net income for the last year?▼
MPLT.BOATS net income for the last year is -161.15M USD.
In which sector is MapLight Therapeutics located?▼
MapLight Therapeutics operates in the Other sector.
When did MapLight Therapeutics complete a stock split?▼
MapLight Therapeutics has not had any recent stock splits.